Ferrosan Medical Device
Ferrosan Medical Devices, a prominent player in the medical device industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 2001, the company has established itself as a leader in the development of innovative surgical and wound care solutions, focusing on advanced haemostatic products that enhance patient outcomes. With a commitment to quality and safety, Ferrosan Medical Devices offers a range of unique products, including absorbable haemostats and surgical dressings, designed to meet the evolving needs of healthcare professionals. The company’s dedication to research and development has positioned it as a trusted partner in the medical community, achieving notable milestones in product innovation and market expansion. Through its expertise, Ferrosan continues to contribute significantly to the advancement of medical technology.
DitchCarbon Score
How does Ferrosan Medical Device's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ferrosan Medical Device's score of 18 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ferrosan Medical Device's reported carbon emissions
In 2023, Ferrosan Medical Devices, headquartered in Denmark (DK), reported total carbon emissions of approximately 15,000,000 kg CO2e, comprising 1,192,000 kg CO2e from Scope 1, 389,000 kg CO2e from Scope 2, and about 14,766,000 kg CO2e from Scope 3 emissions. This represents a slight increase in Scope 3 emissions compared to 2022, where total emissions were approximately 14,073,000 kg CO2e. In 2022, the company achieved a total of about 16,310,000 kg CO2e, with Scope 1 emissions at 1,223,000 kg CO2e and Scope 2 emissions remaining stable at 391,000 kg CO2e. The trend shows a commitment to monitoring and managing emissions across all scopes, although specific reduction targets or initiatives have not been disclosed. Ferrosan Medical Devices has not established formal reduction targets or climate pledges, indicating a potential area for future development in their sustainability strategy. The company continues to focus on energy intensity metrics, with a reported CO2e intensity of 0.0183 for 2023, reflecting ongoing efforts to improve efficiency.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,240,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 391,000 | 000,000 | 000,000 |
| Scope 3 | 12,099,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ferrosan Medical Device is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
